In this interview between Mark Bard, Co-Founder of The DHC Group and Jeff Davis, General Manager of Biopharma at ixlayer, the discussion centers around rethinking diagnostic testing and how it can improve the healthcare triple aim of lowering costs, improving outcomes, and enhancing patient experience. Jeff explains how building a platform to enable remote diagnostic testing through partnerships with labs optimizes the patient experience – this allows tests to be developed and taken at home, with results connected to care providers in the health ecosystem. The two also discussed how testing innovations can help patients with information earlier in their care journey, and how remote testing could improve access issues by reaching underserved populations and addressing social determinants of health. Finally, Mark and Jeff covered opportunities for data insights and how biopharma companies could tailor the testing experience for their patients while maintaining strong privacy standards.